The Food and Drug Administration has approved a Humanitarian Device Exemption (HDE) for an implanted device to treat children who have Thoracic Insufficiency Syndrome, a term used to describe patients who have severe deformities of the chest, spine, and ribs that prevent normal breathing and lung development.
The Food and Drug Administration (FDA) has approved a plastic lens that is permanently implanted into the eye to correct moderate to severe nearsightedness. The lens, called an intraocular lens (IOL), is similar to the type of lens implanted in the eye to restore vision following cataract surgery.
The Food and Drug Administration (FDA) has approved an artificial spinal disc for use in treating pain associated with degenerative disc disease (DDD). The device is intended to replace a diseased or damaged intervertebral disc.
A new $2.8 million effort, partnering public and private funding agencies, will examine how better community design encourages people to be more physically active in their daily lives. Researchers will identify how our built environment contributes to obesity and how environmental changes can combat a growing public health problem.
Inflammation of the head of the penis and foreskin. The disorder can be caused by a bacterial infection, a fungal infection or an allergic reaction. It may also be due to a sexually transmitted infection, such as trichomoniasis. A tighter than normal foreskin may also increase the risk of infection by preventive effective cleaning of the head of the penis. Men with Diabetes Mellitus are more susceptible to the condition. More common in children also.
The Food and Drug Administration (FDA) announced the availability of a qualified health claim for monounsaturated fat from olive oil and reduced risk of coronary heart disease (CHD).
The U.S. Food and Drug Administration has approved Cymbalta, a drug for managing pain associated with diabetic peripheral neuropathy.
U.S. regulators have approved the first chewable tablet medication for Attention Deficit Hyperactivity Disorder.
Prostate cancer is the number one cancer diagnosed in men over age 45. While this disease is very common in the United States, it’s not as common in Japan or China. So, what’s the difference? What we eat could be the key to preventing prostate cancer.
A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), at 12 centers* across the United States and Canada. This test was conceived and is being conducted by NCI’s Early Detection Research Network (EDRN). By examining genetic changes in DNA obtained through urine samples, the test, if successfully validated, will provide a sensitive and non- invasive method of screening for bladder cancer recurrence.